Top Articles
Ruling Limits Lab Onus on Medical Necessity
Judge notes the case involved a well-known whistleblower who has sued labs in the past
CEO SUMMARY: A federal appeals court ruling has established a legal “safe harbor” for clinical laboratories, shifting the burden of proof in False Claims Act cases. By allowing labs to generally rely on physician orders as evidence of medical necessity, the decision pr...
Providers May Be Ordering Inappropriate Vitamin D Tests
Aculabs Inc. discovered that routine and specialized vitamin D testing dramatically increased in 14 years
Heightened consumer interest has been driving demand for vitamin D testing in recent years. However, clinical laboratories should be aware that some providers could be ordering the wrong test to measure levels of the vitamin, in part due to the way that online or...
How to Strategically Recruit and Retain Young Pathologists
If hiring incentives don’t include debt relief and formal mentorships, consider a change
The current pathology landscape is ripe with technological advancements that are creating a surge in talent demand, and yet due to an aging population and a shifting workforce, the supply of qualified pathologists is shrinking. As The Dark Re...
Major Players Back Robotic Phlebotomy with $70M
Vitestro’s Series B funding signals a shift toward automating the pre-analytical workflow
While total laboratory automation has permanently altered the analytical phase of clinical laboratory work, the front-end collection process has remained a stubbornly manual, labor-intensive bottleneck. However, that may be about to change, based on early signs....
In Earnings Calls, Execs at Quest and Labcorp Push for RESULTS Act
Healthy revenue growth at the two biggest national laboratory companies bolstered by M&A activity
Chief executives at Labcorp and Quest Diagnostics made it clear during recent investor calls that they want Congress to pass the RESULTS Act. The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act is seen b...
Pathology Lab Opportunities for Biopharma Collaboration
Once pathology groups identify biopharma needs, they can then begin to serve as problem solvers
As anatomic pathology laboratories face declining reimbursements and other challenges to their bottom lines, one possible solution could involve collaboration with biopharmaceutical companies. But what exactly are drug companies looking for, and how can labs forg...
A Whistleblower Risk for Lab Leaders to Navigate
Our lead briefing details a federal appeals court case that could end up being a landmark decision in favor of clinical la...
Don’t Be at the Mercy of the Tumultuous Healthcare Revolution
Subscribe to The Dark Report for as little as $15.27 per week.
Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.